MegaPro Biomedical Co (ROCO:6827) Beta: 0.8151 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6827 MegaPro Biomedical Co Ltd ROCO:6827
32 GF Score
Price NT$10.70
View Full Analysis

What is MegaPro Biomedical Co Beta?

MegaPro Biomedical Co ROCO:6827 -2.28% 32 Beta is 0.8151 as of Jul. 18, 2026. GuruFocus rates ROCO:6827 with a GF Score™ of 32/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-18), MegaPro Biomedical Co's Beta is 0.8151.


MegaPro Biomedical Co  (ROCO:6827) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


MegaPro Biomedical Co Beta Related Terms


MegaPro Biomedical Co Beta Historical Data

* Premium members only.

The historical data trend for MegaPro Biomedical Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MegaPro Biomedical Co Beta Chart

MegaPro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.82 0.00

MegaPro Biomedical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.82 0.00 0.00

ROCO:6827 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, MegaPro Biomedical Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MegaPro Biomedical Co Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MegaPro Biomedical Co's Beta distribution charts can be found below:

* The bar in red indicates where MegaPro Biomedical Co's Beta falls into.


ROCO:6827
32GF Score
MegaPro Biomedical Co Ltd ROCO:6827
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MegaPro Biomedical Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8151 mean?
MegaPro Biomedical Co (ROCO:6827) has a Beta of 0.8151 as of Jul. 18, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for MegaPro Biomedical Co and its competitors.
Is MegaPro Biomedical Co's Beta too high?
MegaPro Biomedical Co's current Beta is 0.8151. Overall, MegaPro Biomedical Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does MegaPro Biomedical Co's Beta compare to VRTX and REGN?
MegaPro Biomedical Co's Beta of 0.8151 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for MegaPro Biomedical Co and its competitors. MegaPro Biomedical Co's current Beta is 0.8151. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MegaPro Biomedical Co stock overvalued right now?
MegaPro Biomedical Co (ROCO:6827) has a current Beta of 0.8151. The current Beta is 0.8151. MegaPro Biomedical Co's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For MegaPro Biomedical Co (ROCO:6827), the current Beta is 0.8151 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MegaPro Biomedical Co Business Description

Address No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.
32GF Score

Get the complete analysis for ROCO:6827

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.70
Price